Scientific Program

The IPVC 2024 Scientific Program will center around this year’s theme, “Equitable, Evidence-Based Approaches to HPV Disease”. Our Program aims to offer comprehensive insights into various papillomavirus (PV)-related subjects, catering to both experts and non-experts alike, ranging from basic science to clinical applications and global health impact.

Our Scientific Program boasts an exceptional lineup of speakers, consisting of renowned worldwide leaders in the field. Their participation ensures a distinctive platform for education and open discussion, fostering valuable exchanges of knowledge and ideas.

All times are stated in Greenwich Mean Time (GMT) – Edinburgh, UK time.

Program at a Glance Interactive Program

** Program remains subject to change.

Plenaries Workshops ECR Sessions Satellite Symposia Visa InformationIn line with the IPVS mission of addressing the most recent advances across the spectrum of PV research, Conference topics will include:

Prevention and management of HPV-associated diseases and cancer, including non-cervical cancers
The epidemiology of papillomaviruses
Molecular biology of papillomaviruses and cellular responses to infection
Immunity to Papillomavirus infection
What’s new in therapeutic and prophylactic vaccines
Equity in global cervical cancer elimination
Emerging HPV diagnostics and applications
Expanding scientific knowledge to the benefit of the entire research community

Our overarching theme will be “working together as an international, multi-disciplinary community to define, support and promote innovative, evidence-based and sustainable solutions to the burden and pathogenesis of HPV and HPV-associated diseases.”

We look forward to welcoming you to Edinburgh, UK!

To review the scientific program and the confirmed speakers, please click on the drop-down menu below:

Opening Ceremony and IPVC Plenary Session 1

Tuesday, March 28, 2023 | 16:00 – 17:30 | Hall A

Comparing and Contrasting COVID-19 Control With HPV Control and Elimination
Barney Graham (USA)

IPVC Plenary Session 2: HPV Vaccination

Wednesday, March 29, 2023 | 11:00 – 12:30 | Hall A

One-Dose HPV Vaccination Overview and a Focus on the KENSHE Data
Ruanne Barnabas (USA)
New Prophylactic HPV Vaccines
Richard Roden (USA)
Therapeutic Vaccines in Particular With Clinical Outcomes Such As CIN 3
Mayumi Nakagawa (USA)

IPVC Plenary Session 3: Lessons Learned From Other Disease Control Programs such as HIV, Hepatitis B and Anal Cancer Control Approaches

Thursday, March 30, 2023 | 08:30 – 10:00 | Hall A

Lessons Learned From Other Disease Control Programs such as HIV
Helen Rees (South Africa)
What Can We Learn From the Hepatitis B Model in Elimination of HPV Related Diseases?
Mark Kane (USA)
Anal Cancer Control Approaches
Joel Palefsky (USA)

IPVC Plenary Session 4: Carcinogenesis of Cutaneous Papillomaviruses for Non-melanoma Skin Cancer Molecular and Immunological Aspects

Thursday, March 30, 2023 | 15:15 – 16:45 | Hall A

Mastomys coucha: a unique animal model for papillomavirus-induced skin carcinogenesis
Frank Rösl (Germany)
Pros and Cons of Beta HPVs as Causative Agents in Skin Cancer
Denise Galloway (USA)
Epidemiology and Biology of Beta Human Papillomavirus Types
Massimo Tommasino (Italy)

IPVC Plenary Session 5: COVID-19 Effect on the WHO Elimination Plan for Cervical Cancer

Friday, March 31, 2023 | 11:00 – 12:30 | Hall A

COVID-19 Effect on Cervical Screening
Mona Saraiya (USA)
Re-invigorating Efforts Towards Cervical Cancer Elimination: Mitigating the Impact of COVID-19
Karen Canfell (Australia)
What Will It Take (and How) to Achieve Cervical Cancer Elimination Goal by 2030 With a Perspective for Low to Middle-Income Countries?
Yin Ling Woo (Malaysia)

Closing Ceremony and IPVC Plenary Session 6:

Friday, March 31, 2023 | 16:30 – 18:00 | Hall A

The Future Is Now
Douglas Lowy (USA)